Kraig Biocraft Laboratories, Inc.
corporate_fare Company Profile
Kraig Biocraft Laboratories, Inc. (OTC:KBLB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for KBLB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for KBLB spans 10-Q, 424B3, 8-K.
Recent high-impact activity:
- Kraig Biocraft Q3 2026: Going Concern Reiterated, $3.1M Nine-Month Loss, Cash Up to $2.78M
- Kraig Biocraft Fulfills First Commercial Order, Ramps All Three Production Centers
- Kraig Biocraft Boosts Spider Silk Output 30% in Rainy Season, Eyes More Land
- Kraig Biocraft Labs Achieves New Record: Delivers Nearly 2.5 Metric Tons of Recombinant Spider Silk
- Immortalized Silk Gland Cell Breakthrough Promises Enhanced Spider Silk Production for Kraig Biocraft Labs
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 20,105 shares in KBLB as of the October 30, 2026 settlement, a 92.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 25.9% of KBLB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.